Novavax expands Sanofi license for Matrix-M adjuvant use
Go back to Novavax expands Sanofi license for Matrix-M adjuvant use| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.22 -0.12 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.34 | 52 Week High | $9.23 | |||
| Open | $10.50 | 52 Week Low | $1.16 | |||
| Day High | $10.75 | P/E | N/A | |||
| Day Low | $10.05 | EPS | $-0.30 | |||
| Volume | 5,123,313 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 44.24 -0.09 (0.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.33 | 52 Week High | $44.76 | |||
| Open | $44.17 | 52 Week Low | $36.81 | |||
| Day High | $44.36 | P/E | N/A | |||
| Day Low | $44.03 | EPS | $0.00 | |||
| Volume | 1,695,037 | |||||
